Luisa Iacovelli

Pubblicazioni

Titolo	Pubblicato in	Anno
GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disorders	NEUROPHARMACOLOGY	2023
Changes in mGlu5 Receptor Signaling Are Associated with Associative Learning and Memory Extinction in Mice	LIFE	2022
The comparative effects of mGlu5 receptor positive allosteric modulators VU0409551 and VU0360172 on cognitive deficits and signalling in the sub-chronic PCP rat model for schizophrenia	NEUROPHARMACOLOGY	2022
mGlu3 receptor regulates microglial cell reactivity in neonatal rats	JOURNAL OF NEUROINFLAMMATION	2021
Group I metabotropic glutamate receptor-mediated long term depression is disrupted in the hippocampus of WAG/Rij rats modelling absence epilepsy.	NEUROPHARMACOLOGY	2021
MGlu3 receptor regulates microglial cell reactivity in neonatal rats.	JOURNAL OF NEUROINFLAMMATION	2021
The Trace Kynurenine, Cinnabarinic Acid, Displays Potent Antipsychotic-Like Activity in Mice and Its Levels Are Reduced in the Prefrontal Cortex of Individuals Affected by Schizophrenia	SCHIZOPHRENIA BULLETIN	2020
Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia	FRONTIERS IN PSYCHIATRY	2019
Targeting metabotropic glutamate receptors in the treatment of primary brain tumors	CURRENT OPINION IN PHARMACOLOGY	2018
Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system	NEUROPHARMACOLOGY	2018
Targeting mGlu5 metabotropic glutamate receptors in the treatment of cognitive dysfunction in a mouse model of phenylketonuria	FRONTIERS IN NEUROSCIENCE	2018
In vivo non-radioactive assessment of mGlu5 receptor-activated polyphosphoinositide hydrolysis in response to systemic administration of a positive allosteric modulator.	FRONTIERS IN PHARMACOLOGY	2018
Targeting metabotropic glutamate receptors in the treatment of primary brain tumors	CURRENT OPINION IN PHARMACOLOGY	2018
Paradoxical sleep deprivation in rats causes a selective reduction in the expression of type-2 metabotropic glutamate receptors in the hippocampus	PHARMACOLOGICAL RESEARCH	2017
Type-7 metabotropic glutamate receptors negatively regulate α1-adrenergic receptor signalling	NEUROPHARMACOLOGY	2017
Type-7 metabotropic glutamate receptors negatively regulate α1-adrenergic receptor signalling	NEUROPHARMACOLOGY	2017
BDNF rs6265 methylation and genotype interact on risk for schizophrenia	EPIGENETICS	2016
Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors	NEUROPHARMACOLOGY	2016
Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors	NEUROPHARMACOLOGY	2016
Xanthurenic Acid Activates mGlu2/3 metabotropic glutamate receptors and is a potential trait marker for schizophrenia	SCIENTIFIC REPORTS	2015

Pubblicazioni

Progetti di Ricerca